Orsa
London, England, United Kingdom, Europe
Overview
ORSA is a design and compliance consultancy that focuses on health, safety, fire and environmental matters for construction and the built environment. The company provides construction design and management services that support projects from early design through delivery and occupation. ORSA advises clients on regulatory compliance and building safety, including fire safety obligations under evolving legislation. Its consultants work on commercial, hotel, residential, education, retail and heritage schemes, acting as principal designer or similar roles where required. ORSA supports project teams with risk management, documentation, and coordination of safety and environmental requirements across the project lifecycle. The firm also shares updates and guidance on construction, building safety and environmental topics through its news and blogs.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 0
Sector focus
- Building Material
- Construction
- Consulting
- Energy Efficiency
- Environmental Consulting
- Health Care
- Legal
- Project Management
Investment portfolio
- Brenus Pharma
Participated · Series A · Jul 2026
Brenus Pharma is advancing an off-the-shelf platform in immuno-oncology that mimics tumor protein expression to make tumors visible to the immune system. Its lead clinical-stage asset is STC-1010 (NCT06934538), targeting MSS metastatic colorectal cancer, and recent execution across clinical, regulatory and business development milestones has been highlighted by the company. Brenus positions its technology for multi-asset expansion and plans to use new capital to complete the Phase I program for STC-1010 and to advance its next drug candidate. The company has raised a total of €38 million since inception following the €11 million Series A extension. The firm announced the financing from Lyon, France and continues engaging both existing and new international investors to support its development plans.
Team
No current team members are available.